The impact of insurance status on outcomes after surgery for spinal metastases

Hormuzdiyar H. Dasenbrock, Jean Paul Wolinsky, Daniel Sciubba, Timothy F Witham, Ziya L. Gokaslan, Ali Bydon

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Disparities based on insurance status in the American health care system are well established. However, to the authors' knowledge, this is the first study to evaluate variables that may explain differences based on payer type in the outcomes after surgery for spinal metastases. METHODS: Data from the Nationwide Inpatient Sample (2005-2008) were retrospectively extracted. Patients ages 18 to 64 years who underwent surgery for spinal metastases were included. Multivariate logistic regression was performed to calculate the adjusted odds of in-hospital death and the development of a complication for Medicaid recipients and for those without insurance compared with privately insured patients. All analyses were adjusted for differences in patient age, gender, primary tumor histology, socioeconomic status, hospital bed size, and hospital teaching status. RESULTS: A total of 2157 hospital admissions were evaluated. The adjusted odds of in-hospital death were significantly higher for Medicaid recipients (crude rate: 6.5%; odds ratio [OR], 1.79; 95% confidence interval [95% CI], 1.11-2.88 [P =.02]) and uninsured patients (crude rate: 7.7%; OR, 2.15; 95% CI, 1.04-4.46 [P =.04]) compared with privately insured patients (crude rate: 3.8%). Complication rates were also significantly higher for Medicaid recipients (OR, 1.34; 95% CI, 1.04-1.72 [P =.02]). However, after also adjusting for acuity of presentation, the odds of in-hospital death were not significantly different for Medicaid (OR, 1.38; 95% CI, 0.86-2.21 [P =.18]) or uninsured patients (OR, 1.86; 95% CI, 0.90-3.83 [P =.09]); in addition, complication rates did not appear to differ significantly. CONCLUSIONS: This nationwide study suggests that disparities based on insurance status for patients undergoing surgery for spinal metastases may be attributable to a higher acuity of presentation.

Original languageEnglish (US)
Pages (from-to)4833-4841
Number of pages9
JournalCancer
Volume118
Issue number19
DOIs
StatePublished - Oct 1 2012

Fingerprint

Insurance Coverage
Neoplasm Metastasis
Medicaid
Odds Ratio
Confidence Intervals
Hospital Bed Capacity
Insurance
Social Class
Teaching Hospitals
Inpatients
Histology
Logistic Models
Delivery of Health Care
Neoplasms

Keywords

  • disparities
  • insurance status
  • Medicaid
  • Nationwide Inpatient Sample
  • spinal fusion
  • spinal metastases
  • spine surgery

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The impact of insurance status on outcomes after surgery for spinal metastases. / Dasenbrock, Hormuzdiyar H.; Wolinsky, Jean Paul; Sciubba, Daniel; Witham, Timothy F; Gokaslan, Ziya L.; Bydon, Ali.

In: Cancer, Vol. 118, No. 19, 01.10.2012, p. 4833-4841.

Research output: Contribution to journalArticle

Dasenbrock, Hormuzdiyar H. ; Wolinsky, Jean Paul ; Sciubba, Daniel ; Witham, Timothy F ; Gokaslan, Ziya L. ; Bydon, Ali. / The impact of insurance status on outcomes after surgery for spinal metastases. In: Cancer. 2012 ; Vol. 118, No. 19. pp. 4833-4841.
@article{bfae4df157da4e5ca373cc40379b32aa,
title = "The impact of insurance status on outcomes after surgery for spinal metastases",
abstract = "BACKGROUND: Disparities based on insurance status in the American health care system are well established. However, to the authors' knowledge, this is the first study to evaluate variables that may explain differences based on payer type in the outcomes after surgery for spinal metastases. METHODS: Data from the Nationwide Inpatient Sample (2005-2008) were retrospectively extracted. Patients ages 18 to 64 years who underwent surgery for spinal metastases were included. Multivariate logistic regression was performed to calculate the adjusted odds of in-hospital death and the development of a complication for Medicaid recipients and for those without insurance compared with privately insured patients. All analyses were adjusted for differences in patient age, gender, primary tumor histology, socioeconomic status, hospital bed size, and hospital teaching status. RESULTS: A total of 2157 hospital admissions were evaluated. The adjusted odds of in-hospital death were significantly higher for Medicaid recipients (crude rate: 6.5{\%}; odds ratio [OR], 1.79; 95{\%} confidence interval [95{\%} CI], 1.11-2.88 [P =.02]) and uninsured patients (crude rate: 7.7{\%}; OR, 2.15; 95{\%} CI, 1.04-4.46 [P =.04]) compared with privately insured patients (crude rate: 3.8{\%}). Complication rates were also significantly higher for Medicaid recipients (OR, 1.34; 95{\%} CI, 1.04-1.72 [P =.02]). However, after also adjusting for acuity of presentation, the odds of in-hospital death were not significantly different for Medicaid (OR, 1.38; 95{\%} CI, 0.86-2.21 [P =.18]) or uninsured patients (OR, 1.86; 95{\%} CI, 0.90-3.83 [P =.09]); in addition, complication rates did not appear to differ significantly. CONCLUSIONS: This nationwide study suggests that disparities based on insurance status for patients undergoing surgery for spinal metastases may be attributable to a higher acuity of presentation.",
keywords = "disparities, insurance status, Medicaid, Nationwide Inpatient Sample, spinal fusion, spinal metastases, spine surgery",
author = "Dasenbrock, {Hormuzdiyar H.} and Wolinsky, {Jean Paul} and Daniel Sciubba and Witham, {Timothy F} and Gokaslan, {Ziya L.} and Ali Bydon",
year = "2012",
month = "10",
day = "1",
doi = "10.1002/cncr.27388",
language = "English (US)",
volume = "118",
pages = "4833--4841",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "19",

}

TY - JOUR

T1 - The impact of insurance status on outcomes after surgery for spinal metastases

AU - Dasenbrock, Hormuzdiyar H.

AU - Wolinsky, Jean Paul

AU - Sciubba, Daniel

AU - Witham, Timothy F

AU - Gokaslan, Ziya L.

AU - Bydon, Ali

PY - 2012/10/1

Y1 - 2012/10/1

N2 - BACKGROUND: Disparities based on insurance status in the American health care system are well established. However, to the authors' knowledge, this is the first study to evaluate variables that may explain differences based on payer type in the outcomes after surgery for spinal metastases. METHODS: Data from the Nationwide Inpatient Sample (2005-2008) were retrospectively extracted. Patients ages 18 to 64 years who underwent surgery for spinal metastases were included. Multivariate logistic regression was performed to calculate the adjusted odds of in-hospital death and the development of a complication for Medicaid recipients and for those without insurance compared with privately insured patients. All analyses were adjusted for differences in patient age, gender, primary tumor histology, socioeconomic status, hospital bed size, and hospital teaching status. RESULTS: A total of 2157 hospital admissions were evaluated. The adjusted odds of in-hospital death were significantly higher for Medicaid recipients (crude rate: 6.5%; odds ratio [OR], 1.79; 95% confidence interval [95% CI], 1.11-2.88 [P =.02]) and uninsured patients (crude rate: 7.7%; OR, 2.15; 95% CI, 1.04-4.46 [P =.04]) compared with privately insured patients (crude rate: 3.8%). Complication rates were also significantly higher for Medicaid recipients (OR, 1.34; 95% CI, 1.04-1.72 [P =.02]). However, after also adjusting for acuity of presentation, the odds of in-hospital death were not significantly different for Medicaid (OR, 1.38; 95% CI, 0.86-2.21 [P =.18]) or uninsured patients (OR, 1.86; 95% CI, 0.90-3.83 [P =.09]); in addition, complication rates did not appear to differ significantly. CONCLUSIONS: This nationwide study suggests that disparities based on insurance status for patients undergoing surgery for spinal metastases may be attributable to a higher acuity of presentation.

AB - BACKGROUND: Disparities based on insurance status in the American health care system are well established. However, to the authors' knowledge, this is the first study to evaluate variables that may explain differences based on payer type in the outcomes after surgery for spinal metastases. METHODS: Data from the Nationwide Inpatient Sample (2005-2008) were retrospectively extracted. Patients ages 18 to 64 years who underwent surgery for spinal metastases were included. Multivariate logistic regression was performed to calculate the adjusted odds of in-hospital death and the development of a complication for Medicaid recipients and for those without insurance compared with privately insured patients. All analyses were adjusted for differences in patient age, gender, primary tumor histology, socioeconomic status, hospital bed size, and hospital teaching status. RESULTS: A total of 2157 hospital admissions were evaluated. The adjusted odds of in-hospital death were significantly higher for Medicaid recipients (crude rate: 6.5%; odds ratio [OR], 1.79; 95% confidence interval [95% CI], 1.11-2.88 [P =.02]) and uninsured patients (crude rate: 7.7%; OR, 2.15; 95% CI, 1.04-4.46 [P =.04]) compared with privately insured patients (crude rate: 3.8%). Complication rates were also significantly higher for Medicaid recipients (OR, 1.34; 95% CI, 1.04-1.72 [P =.02]). However, after also adjusting for acuity of presentation, the odds of in-hospital death were not significantly different for Medicaid (OR, 1.38; 95% CI, 0.86-2.21 [P =.18]) or uninsured patients (OR, 1.86; 95% CI, 0.90-3.83 [P =.09]); in addition, complication rates did not appear to differ significantly. CONCLUSIONS: This nationwide study suggests that disparities based on insurance status for patients undergoing surgery for spinal metastases may be attributable to a higher acuity of presentation.

KW - disparities

KW - insurance status

KW - Medicaid

KW - Nationwide Inpatient Sample

KW - spinal fusion

KW - spinal metastases

KW - spine surgery

UR - http://www.scopus.com/inward/record.url?scp=84866516363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866516363&partnerID=8YFLogxK

U2 - 10.1002/cncr.27388

DO - 10.1002/cncr.27388

M3 - Article

C2 - 22294322

AN - SCOPUS:84866516363

VL - 118

SP - 4833

EP - 4841

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 19

ER -